Announcing the new issue of Prime’s managed care report, featuring the latest trends and updates in medical and pharmacy benefits

March 26, 2024

Prime Therapeutics/Magellan Rx (Prime/MRx) today launched the spring edition of Magellan Rx Report featuring timely topics such as single-treatment gene therapies and value-based contracting to address the dynamic growth trend and cost of gene and cell therapies. The triannual Magellan Rx Report provides an in-depth analysis of trends associated with high-cost, innovative therapies and the latest updates to inform our clients’ coverage and benefit decisions. 

The Magellan Rx Report spring edition includes expert commentary on the following topics: 

  • Single-treatment gene therapies and proper management  
  • Myasthenia gravis treatment advances and associated payer impact 
  • Ophthalmic update on new treatment options and management strategies 
  • Tumor biomarkers in breast cancer – ESR1 testing and targeted therapies 
  • Product spotlight: Leqembi for Alzheimer’s disease 
  • Update on new FDA-approved biosimilars 
  • Pipeline drug list update 

Download a copy of the report to go deeper into these timely trends. 

Stay current on ways Prime/MRx is reimagining pharmacy management to provide the same care we would want for our loved ones. 

Related news


April 5, 2024

LISTEN NOW: Revolutionizing Healthcare: Prime & Capital Rx’s Game-Changing Alliance – Pharmacy Friends podcast

In this special episode of the Pharmacy Friends podcast, the CEOs of Prime Therapeutics, Mostafa Kamal, and Capital Rx, AJ Loiacono, join Michael Passanante, SVP of Marketing & Communications at Capital Rx, to share the story behind the strategic alliance between the organizations and their vision to reimagine pharmacy.


March 19, 2024

Healthcare Businesswomen’s Association names Simone Ndujiuba and Jacki Shugart among 2024 Rising Stars 

Prime Therapeutics/Magellan Rx’s Director of Clinical Strategy and Innovation Simone Ndujiuba and Senior Program Manager Jacki Shugart honored for female leadership in the health care industry


February 2, 2024

Prime Therapeutics/Magellan Rx honors World Cancer Day, supports innovative oncology care

Prime is committed to closing gaps in cancer care by delivering meaningful oncology solutions to help people living with cancer.